Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 25, 2018Wiley Interdisciplinary Reviews - RNA

Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

View Full Paper
Ask AI
Bookmark
Share

Authors

LULaura M. UrbanskiJackson LaboratoryNLNathan K. LeclairJackson LaboratoryOAOlga AnczukówUConn Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Urbanski et al. (2018) studied this question.

synapsesocial.com/papers/6a896a5465b7d5248dc121e9https://doi.org/10.1002/wrna.1476
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer2015 · 453 citations
  2. 2A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer2016 · 80 citations
  3. 3Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay2010 · 83 citations
  4. 4KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival2013 · 129 citations